Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation

Molecular Immunology
Yi LiChengping Hu

Abstract

Acute respiratory distress syndrome(ARDS)is a severe clinical disorder characterized by its acute onset, diffuse alveolar damage, intractable hypoxemia, and non-cardiogenic pulmonary edema. Acute lung injury(ALI) can trigger persistent lung inflammation and fibrosis through activation of the NLRP3 inflammasome and subsequent secretion of mature IL-1β, suggesting that the NLRP3 inflammasome is a potential therapeutic target for ALI, for which new therapeutic approaches are needed. Our present study aims to assess whether pirfenidone,with anti-fibrotic and anti-inflammatory properties, can improve LPS-induced inflammation and fibrosis by inhibiting NLRP3 inflammasome activation. Male C57BL/6 J mice were intratracheally injected with LPS to induce ALI. Mice were administered pirfenidone by oral gavage throughout the entire experimental course. The mouse macrophage cell line (J774 A.1) was incubated with LPS and ATP, with or without PFD pre-treatment. We demonstrated that PFD remarkably ameliorated LPS-induced pulmonary inflammation and fibrosis and reduced IL-1β and TGF-β1 levels in bronchoalveolar lavage fluid(BALF). Pirfenidone substantially reduced NLRP3 and ASC expression and inhibited caspase-1 activation and IL-1β maturation...Continue Reading

Associated Clinical Trials

Citations

Jan 23, 2020·American Journal of Respiratory Cell and Molecular Biology·Saleela M RuwanpuraPhilip G Bardin
Apr 9, 2020·Frontiers in Cell and Developmental Biology·Lijun ZhaoFang Liu
Jul 13, 2020·Intensive Care Medicine·Shahd HorieJohn G Laffey
Jul 6, 2019·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Bin WangQin Liu
Nov 3, 2020·Expert Opinion on Drug Discovery·Hongliang ZhangJinhui Tao
Oct 30, 2020·International Journal of Molecular Sciences·Andrey V MarkovEvgeniya B Logashenko
Dec 6, 2020·Current Opinion in Critical Care·Hector GonzalezJohn G Laffey
Sep 3, 2019·Biochemical and Biophysical Research Communications·Yanjun ZengPinhua Pan
Jul 17, 2020·American Journal of Respiratory and Critical Care Medicine·Steven L BrodyYongjian Liu
Feb 9, 2021·BioMed Research International·Huihui ZhangYuanyi Peng
Feb 16, 2021·Frontiers in Medicine·Soroush Seifirad, Lance Alquran
Jan 29, 2021·The Journal of Pathology·Gwenda F VasseBarbro N Melgert
Mar 7, 2021·Biomolecules·Margherita SistoSabrina Lisi
Apr 1, 2021·Life Sciences·Pragya PrasannaSulakshana Sulakshana
Apr 24, 2021·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yet H Khor
Jun 1, 2021·Immunopharmacology and Immunotoxicology·May Ahmed ShawkiRiham S Said
Jun 9, 2021·The Indian Journal of Tuberculosis·Deependra Kumar RaiRahul Kumar
Jun 29, 2021·Frontiers in Immunology·Wen-Juan ZhangHui Wang
Feb 2, 2021·Canadian Journal of Physiology and Pharmacology·Qingxia LiuYing Meng
Jul 31, 2021·Frontiers in Cell and Developmental Biology·Yuqing ZhangXiaolin Tong
Apr 6, 2021·Experimental Animals·Wenlian WangJunfeng Hu
May 11, 2021·American Journal of Respiratory Cell and Molecular Biology·Ru DingJianxin Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here